CN104366179A - 一种睡莲健胃含片的制作方法 - Google Patents
一种睡莲健胃含片的制作方法 Download PDFInfo
- Publication number
- CN104366179A CN104366179A CN201310357676.1A CN201310357676A CN104366179A CN 104366179 A CN104366179 A CN 104366179A CN 201310357676 A CN201310357676 A CN 201310357676A CN 104366179 A CN104366179 A CN 104366179A
- Authority
- CN
- China
- Prior art keywords
- stomach
- water
- lozenge
- strengthening
- water lily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000209490 Nymphaea Species 0.000 title claims abstract description 13
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 title claims abstract description 13
- 239000007937 lozenge Substances 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 238000005728 strengthening Methods 0.000 title abstract description 7
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 33
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 33
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 33
- 210000002784 stomach Anatomy 0.000 claims abstract description 27
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 24
- 235000008397 ginger Nutrition 0.000 claims abstract description 24
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 20
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 20
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 20
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 20
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 19
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 5
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 5
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 244000273928 Zingiber officinale Species 0.000 claims abstract 4
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 19
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 17
- 241001674939 Caulanthus Species 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000007598 dipping method Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 238000005469 granulation Methods 0.000 claims description 5
- 230000003179 granulation Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 25
- 235000005911 diet Nutrition 0.000 abstract description 4
- 241000411851 herbal medicine Species 0.000 abstract description 4
- 230000001788 irregular Effects 0.000 abstract description 4
- 229930006000 Sucrose Natural products 0.000 abstract description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 3
- 230000037213 diet Effects 0.000 abstract description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 3
- 239000011707 mineral Substances 0.000 abstract description 3
- 240000007124 Brassica oleracea Species 0.000 abstract description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 abstract description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 abstract description 2
- 229960004106 citric acid Drugs 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 206010000059 abdominal discomfort Diseases 0.000 abstract 1
- 230000001133 acceleration Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 229940057948 magnesium stearate Drugs 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 241000234314 Zingiber Species 0.000 description 20
- 241001092040 Crataegus Species 0.000 description 16
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 208000007107 Stomach Ulcer Diseases 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 201000005917 gastric ulcer Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000000718 duodenal ulcer Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 208000006595 Necrotizing Ulcerative Gingivitis Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010067197 Tinea manuum Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002802 cardiorespiratory effect Effects 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229960005137 succinic acid Drugs 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008587 ulcerative stomatitis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种睡莲健胃含片的制作方法,用到的原料主要为睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。经过睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝经特殊工艺制成。现代生活节奏的加快,人们对饮食的不规律,胃病发生率越来越高。本发明提供一种睡莲健胃含片,集多种有健胃活性的中草药的功效于一身,纯天然中草药取材,有很好的健胃效果,食用简单、携带方便。含片中用木糖醇取代了蔗糖,适用人群更广。该含片适用于肠胃不适的人群服用。
Description
技术领域 本发明涉及一种睡莲健胃含片的制作方法,用到的原料主要为睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝、木糖醇、麦芽糊精、柠檬酸、硬脂酸镁和崂山矿泉水。经过睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装而成。现代生活节奏的加快,人们对饮食的不规律,胃病发生率越来越高。本发明提供一种睡莲健胃含片,集多种有健胃活性的中草药的功效于一身,纯天然中草药取材,有很好的健胃效果,食用简单、携带方便。含片中用木糖醇取代了蔗糖,适用人群更广。该含片适用于肠胃不适的人群服用。
背景技术 现代人的生活不断提高,造成了营养不均衡,饮食结构不合理;既追求吃得精、吃得香。嘴吃香了,身体却受影响了,出现了三高三低症状,产生了高血压、高血脂、高血糖,肥胖人群不断增加。除此之外,由于饮食不规律及生活压力大,胃病的发生率也越来越高。诱发胃功能紊乱的原因有以下几个方面:1.生活因素:可能是吃了某些刺激性食物或者药物引起的,如辛辣、生冷、过硬、过酸的食物,吸烟喝酒,服用了非甾体抗炎药物等,均可导致胃难受的现象。另外,吃饭不规律,饥一顿饱一顿、暴饮暴食,也可出现此类症状。2、精神因素:由于生活压力大,长期处于紧张、忧虑、焦急、抑郁等不良情绪中,可导致胃难受,还可出现胃肠功能紊乱的症状。3、疾病因素:很多疾病,均可导致胃难受的症状,如急性胃炎、慢性胃炎、胃溃疡、十二指肠溃疡、胃、十二指肠复合型溃疡、胃出血、胃的良恶性肿瘤等。其中,胃溃疡、十二指肠溃疡、慢性胃炎占绝大多数。因此加强胃部消化功能,即健胃,还是很有必要的。本发明提供的这种睡莲健胃含片,集合了睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝的健胃功效,是一种适合肠胃不适人群食用的绿色保健食品。
发明内容 本发明的要点在于将睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装而成。
本发明选用的材料用量如下(组分及其重量百分比%):睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝(5:4:4:2:2:2:2:1)浓缩液20.0-30.0;木糖醇40.0-60.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁0.4。
睡莲花:睡莲花性温味苦甘,具有活血止血、化瘀止痛、消风祛湿、清心凉血、补脾涩肠、生津止渴等功效。
莲叶:莲叶性平味苦,含丰富的维生素C及化学成分主要有荷叶碱、柠檬酸、苹果酸、葡萄糖酸、草酸、琥珀酸及其它抗有丝分裂作用的碱性成分。药理研究发现,荷叶具有解热、清暑、醒脾、化瘀、止血、抑菌、解痉、除湿气作用。
莲藕:消食止泻,开胃清热,滋补养性,预防内出血,是妇孺童妪、体弱多病者上好的流质食品和滋补佳珍。
山楂:山楂能防治心血管疾病,具有扩张血管、强心、增加冠脉血流量、改善心脏活力、兴奋中枢神经系统、降低血压和胆固醇、软化血管及利尿和镇静作用;防治动脉硬化,防衰老、抗癌的作用。山楂酸还有强心作用,对老年性心脏病也有益处。它能开胃消食,特别对消肉食积滞作用更好,很多助消化的药中都采用了山楂;山楂对子宫有收缩作用,在孕妇临产时有催生之效,并能促进产后子宫复原;能增强机体的免疫力,有防衰老、抗癌的作用。山楂中有平喘化痰、抑制细菌、治疗腹痛腹泻的成分。
陈皮:陈皮的作用有很多,主治脾胃气滞湿阻、胸膈满闷、脘腹胀痛、不思饮食、呕吐秽逆、二便不利等症。在烹调中加入陈皮有调和理气和化痰作用。同时,陈皮还具有燥湿、利水通便的功效,对脾胃不和、水肿和便秘都有很好的功效,而且对于解蟹毒、酒毒也有一定的作用。陈皮最重要的几个功效是能理气,祛除体内的湿邪,调整脾胃功能。心肺系统的疾病如上呼吸道感染,痰多咳喘,胸闷;脾胃的毛病,如胃痛,消化不良,呕吐等,一般生活中的小病,只要跟呼吸道和消化系统有关的,如风寒感冒,咳嗽痰多,消化不良等,除了热病都能用陈皮食疗。
生姜:生姜性味辛温,有散寒发汗、化痰止咳、和胃、止呕等多种功效。喝生姜红糖水治感冒;生姜有“呕家圣药”之称;生姜还可用于治疗肠炎、痢疾等;生姜外擦对白癜风、斑秃、手癣也有一定治疗效果。民间有“早上三片姜,赛过喝参汤”及“十月生姜小人参”之说。还有“每天三片姜,不劳医生开处方”的谚语。
山药:铁棍山药因富含18种氨基酸和10余种微量元素,及其它矿物质,所以有健脾胃、补肺肾、补中益气、健脾补虚,固肾益精、益心安神等作用。鲜山药富含多种维生素、氨基酸和矿物质,可以防治人体脂质代谢异常,以及动脉硬化,对维护胰岛素正常功能也有一定作用,有增强人体免疫力,益心安神,宁咳定喘,延缓衰老等保健作用。山药中的铜离子与结缔组织对人体发育有极大帮助,对血管系统疾病有明显疗效,铁棍山药中的钙,对伤筋损骨、骨质疏松,牙齿脱落有极高的疗效,对冻疮、糖尿 病、肝炎、小儿泻泄、遗尿症、婴儿消化不良、溃疡性口腔炎、肺结核、妇女月经带下等患者也有很好的疗效,久用可耳聪目明,延年益寿。山药中富含大量蛋白质、B族维生素、维生素C、维生素E、葡萄糖、粗蛋白氨基酸、胆汁碱、尿囊素等;其中重要的营养成分薯蓣皂是合成女性荷尔蒙的先驱物质,滋阴补阳、增强新陈代谢的功效;而新鲜块茎中含有的多糖蛋白成分的粘液质、消化酵素等,可预防心血管脂肪沉积,有助于胃肠的消化和吸收。
甘蓝:甘蓝性平味甘,无毒,入胃、肾二经。甘蓝是世界卫生组织曾推荐的最佳蔬菜之一,也被誉为天然“胃菜”。其所含的维生素K1及维生素U,不仅能抗胃部溃疡、保护并修复胃黏膜组织,还可以保持胃部细胞活跃旺盛,降低病变的几率。患胃溃疡及十二指肠溃疡的人,可每天以椰菜榨汁饮用,还可混合蜂蜜食用,有促进溃疡愈合的作用。
本发明生产工艺: 睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
本发明产品的制备方法是:
1)预处理:睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
本发明具有以下优点:
1) 集合了睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝的健胃功效,效果显著;
2)食用简单,携带方便;
3)质量优,长期食用无副作用;
4)木糖醇取代了蔗糖,适用人群更广。
具体实施方式:下面结合实施例对本发明作进一步的详细说明:
以100kg本发明产品为例:
1.配方:(组分及其重量百分比%):睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝(5:4:4:2:2:2:2:1)浓缩液20.0-30.0;木糖醇40.0-60.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁0.4。
2. 生产流程: 睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3.制备方法:
1)预处理:睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
Claims (3)
1.本发明涉及一种睡莲健胃含片的制作方法,其特征在于具有如下配方(组分及其重量百分比%):
睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝(5:4:4:2:2:2:2:1)浓缩液20.0-30.0;木糖醇40.0-60.0;麦芽糊精10.0-15.0;柠檬酸1.0;硬脂酸镁0.4。
2.一种权利要求1所述的一种睡莲健胃含片的制作方法,其特征在于具有如下的生产工艺:
睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝→漂洗→粉碎→加水热浸提→保温→粗滤→硅藻土过滤机→真空浓缩锅→浓缩液→与其他辅料混合→混合机造粒→干燥→压片→灭菌→包装。
3.一种权利要求1所述的一种睡莲健胃含片的制作方法,其特征在于具有如下的制备方法:
1)预处理:睡莲花、莲叶、莲藕、山楂、陈皮、生姜、山药、甘蓝洗净、切碎、烘干,粉碎机破碎成细粉;
2)热浸提取:将原材料细粉放入夹层锅中,加30倍的崂山矿泉水,热水浸提(90-100度)并保温4小时;
3)过滤:先用60目滤网粗滤,再经过硅藻土过滤机进行细滤;
4)浓缩:把滤液输入真空浓缩锅(真空度97kPa,温度55左右),将液体浓缩至原加水量1/20时,成为浓缩液;
5)将浓缩液和其他辅料按一定比例充分混合;
6)混合充分的软料投入摇摆式颗粒剂中进行造成粒,再把颗粒放在真空干燥机中进行干燥,真空度控制在0.053-0.060Mpa,温度控制在60-65度使颗粒的水分控制在小于3%左右;
7)在干燥颗粒中加入润滑剂(硬脂酸镁,4‰)混匀后,压片,紫外线下照射30分钟,然后及时包装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357676.1A CN104366179A (zh) | 2013-08-16 | 2013-08-16 | 一种睡莲健胃含片的制作方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310357676.1A CN104366179A (zh) | 2013-08-16 | 2013-08-16 | 一种睡莲健胃含片的制作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104366179A true CN104366179A (zh) | 2015-02-25 |
Family
ID=52545570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310357676.1A Pending CN104366179A (zh) | 2013-08-16 | 2013-08-16 | 一种睡莲健胃含片的制作方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104366179A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106165885A (zh) * | 2016-04-17 | 2016-11-30 | 马鞍山市志诚科技有限公司 | 一种防治慢性浅表性胃炎的营养配方纳米颗粒及制备加工方法 |
CN111084376A (zh) * | 2020-01-03 | 2020-05-01 | 孙幼雄 | 一种治疗胃病的食羹及制备方法 |
-
2013
- 2013-08-16 CN CN201310357676.1A patent/CN104366179A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106165885A (zh) * | 2016-04-17 | 2016-11-30 | 马鞍山市志诚科技有限公司 | 一种防治慢性浅表性胃炎的营养配方纳米颗粒及制备加工方法 |
CN111084376A (zh) * | 2020-01-03 | 2020-05-01 | 孙幼雄 | 一种治疗胃病的食羹及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102726565A (zh) | 荞菊养生茶及其制备方法 | |
CN103609992B (zh) | 一种高丽红参膏的制备方法 | |
CN103828954A (zh) | 一种减肥茶及其制作方法 | |
CN101238893B (zh) | 一种高膳食纤维鹰嘴豆营养粉及其制备方法和用途 | |
CN103734835A (zh) | 一种山药活性功能饮料及其制备方法 | |
CN103610072A (zh) | 一种降血糖海参口服液的制造方法 | |
CN102113534A (zh) | 一种具有治疗糖尿病功能的月饼及其制备方法 | |
CN103749827B (zh) | 一种高丽红参无花果茶的制备方法 | |
CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
CN103263054B (zh) | 一种降血压功能性饮品 | |
CN105029421A (zh) | 调理痰湿体质的保健品 | |
CN102293290B (zh) | 一种消食润肠茶及其制备方法 | |
CN102048215B (zh) | 一种保健饮料及其制备方法 | |
CN104365899A (zh) | 一种睡莲速溶健胃茶 | |
CN107541403A (zh) | 一种黄桃果酒及生产方法 | |
CN104366179A (zh) | 一种睡莲健胃含片的制作方法 | |
CN105875727A (zh) | 一种玫瑰养颜面包及其制作方法 | |
CN101642181A (zh) | 一种减肥口香糖的制作方法 | |
CN104664505B (zh) | 一种改善睡眠的饮料 | |
CN104367969A (zh) | 一种睡莲健胃胶囊 | |
CN106615363A (zh) | 一种减肥保健茶及其制备方法 | |
CN106937718A (zh) | 一种双海藻花粉植物复合饮料及其制备方法 | |
CN103719863B (zh) | 一种高丽红参咀嚼片的制备方法 | |
CN104922504A (zh) | 治疗动脉粥样硬化的醋饮及制备方法 | |
CN103610068A (zh) | 一种降血脂海参口服液的制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150225 |
|
WD01 | Invention patent application deemed withdrawn after publication |